Subscribe to Newsletter

August 2022 Issue of The Ophthalmologist

In this month’s editorial, Geoffrey Potjewyd discusses the recent allegations of image manipulation in a major Alzheimer’s disease paper and the importance of research integrity.
Our Upfront section covers features the latest industry and research news – the pandemic’s effect on AMD progression, a single injection that could treat inherited blindness, a pathway that lets people see shadows in the dark, and ethnic disparities in vision loss risk in primary open angle glaucoma patients.
This issue’s cover feature is a double bill! In the first part, some of the biggest names in the field – John Hovanesian, Oliver Findl, David Chang, and Dan Morris – highlight the issue of sustainability and discuss the initiatives being undertaken to reduce ophthalmology’s environmental impact. Following this is the annual Art of Eyes gallery feature, showcasing the best ophthalmic images created by photographers, cartoonists, painters, and even those using artificial intelligence to assist with their artistic endeavors.
In our Cornea and OSD section, Richard L. Lindstrom assesses the cost-effectiveness of corneal collagen cross-linking for keratoconus, and in Glaucoma, Robert A. Van der Vaart talks about the benefit of incorporating MIGS into comprehensive practice and shares his favorite device. In the Retina section, Thomas Aaberg, Jr. discusses how encapsulated cell therapy could offer a continuous and targeted treatment for under- and untreated eye diseases.
Finally, we sit down with Marc Safran, Former Medical Director, Syracuse Specialty Surgery Center, and an award-winning photographer, based in Syracuse, New York, USA.

Register to download
Register here to download any issue of The Ophthalmologist for FREE.
Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Profession Professional Development

Look Up

| Dan Morris | 7 min read

Sustainability is now mainstream – so how can ophthalmology reduce its carbon footprint?

Subspecialties Retina

Delay No More

| Geoffrey Potjewyd | 2 min read

How have delays caused by COVID-19 for anti-VEGF treatment affected AMD patients disease progression?

Subspecialties Cataract

Clearing the Path

| Oscelle Boye

Is treating cataracts without surgery a vision of the future?

Subspecialties Neuro-ophthalmology

Another Step Forward

| Bruce Cree | 5 min read

The global lead investigator for the N-MOmentum trial, Bruce Cree, explains how UPLIZNA enables stratified treatment of NMOSD

Subspecialties Retina

The ON-OFF Switch

| Oscelle Boye | 3 min read

Scientists shine a light on the mechanism that allows people to see shadows in the dark

Subspecialties Retina

Conditions for Success

| Geoffrey Potjewyd | 2 min read

A cell medium cocktail created from stem cells may be the solution to oxidative stress in the retina

Subspecialties Cornea / Ocular Surface

Costing Up Cross-Linking

| Richard L. Lindstrom | 6 min read

According to modeling, corneal collagen cross-linking is a cost-effective method of treating keratoconus

Subspecialties Glaucoma

My MIGS of Choice, with Robert A. Van der Vaart

| Robert A. Van der Vaart | 6 min read

What are the benefits of incorporating MIGS into your comprehensive practice?

Subspecialties Retina

A Tiny Factory

| Thomas Aaberg, Jr. | 5 min read

Scaffolding a solution to macular telangiectasia with encapsulated cell therapy

Business & Profession Professional Development

Double Exposure

| Oscelle Boye | 6 min read

Sitting Down With… Marc Safran, Former Medical Director, Syracuse Specialty Surgery Center, and award-winning photographer, Syracuse, New York, USA

Other issues of 2022


The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: